CCT3 drives Sorafenib resistance by inhibiting TFRC-mediated iron uptake in HCC

Huihui Zhu(First Affiliated Hospital Zhejiang University), Feiyang Ji(Sir Run Run Shaw Hospital)

bioRxiv (Cold Spring Harbor Laboratory)

December 15, 2023

10.1101/2023.12.14.571783

Cited by 0

Related Papers

CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis

|Journal of Experimental & Clinical Cancer Research|2024|26